BioVie Inc (NASDAQ:BIVI, NASDAQ:BIVIW) announced that has completed the last on-treatment visit in its Phase 2 ADDRESS-LC clinical trial evaluating bezisterim in adults with Long COVID, with topline ...

BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for neurological and neurodegenerative diseases, today announced that the last ...

Quantum technologies promise secure communication networks, powerful forms of computing and new sensing tools. One of the major challenges, however, is that different quantum systems often operate at ...

Phaseburn One is a new Synthesizer plugin that is built around a phase-locked loop and other distinct oscillator engines.

Yale researchers mapped noise in microwave-driven Josephson circuits to time-dependent Hamiltonian models, a key step for ...

Bitwig Studio 6 is a major upgrade for the Berlin-based DAW with significant core feature upgrades, improvements, and more.

Operating matter-wave interferometers as quantum detectors for fundamental physics or inertial sensors with unprecedented ...

REZOLVE-AD study met all primary and key secondary endpoints, including EASI-75, EASI-90, Itch NRS, vIGA-AD and BSA, on rezpegaldesleukin 24 µg/kg q2w ...

A research team at City University of Hong Kong (CityUHK) has developed a new optical corner-detection imaging method that ...

Tiziana Life Sciences Ltd (NASDAQ:TLSA) announced that it will present a poster on its Phase 2a BANYAN clinical trial of ...

ALS Nexus 2026, organized by the ALS Association, takes place August 23–26, 2026, bringing together researchers, clinicians, people living with ALS, caregivers, and advocates to accelerate progress ...

"Dosing the first patient in the FUNCTION-DMD study earlier this month was a significant milestone for Precision BioSciences and for the Duchenne community," said Sam Collins, M.D., Senior Vice ...